GlassScriptPhysician profile
Hudson D Stern
NPI 1285085373
$5,195.88
in general payments reported to CMS, 2019-2025
17 companies · $1,151 in 2025
The $1,151 reported for 2025 was more than what 76% of Retina Specialist providers received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,122 · 2020: $225 · 2021: $206 · 2022: $823 · 2023: $682 · 2024: $987 · 2025: $1,151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,820.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,820.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $857.67 | 2019-2025 | Constellation, Ngenuity |
| Abbvie INC. | $628.30 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $611.20 | 2019-2025 | Eylea Hd, Eylea |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $596.57 | 2019-2020 | |
| Apellis Pharmaceuticals, INC. | $550.50 | 2022-2025 | Syfovre |
| Sight Sciences, INC. | $426.70 | 2019-2024 | Omni Surgical System |
| Glaukos Corporation | $404.07 | 2019-2025 | Istent Trabecular Micro-Bypass System Model Is3, Istent Infinite |
| Alimera Sciences, INC. | $335.80 | 2022-2023 | Iluvien |
| Novartis Pharmaceuticals Corporation | $155.84 | 2019 | |
| Genentech USA, INC. | $129.84 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $112.73 | 2019 | |
| Eyepoint US, INC. | $112.60 | 2022 | |
| Mallinckrodt Hospital Products INC. | $92.40 | 2024-2025 | Acthar |
| Bausch & Lomb Americas INC. | $88.33 | 2025 | Stellaris |
| Iridex Corporation | $41.06 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sandoz INC. | $30.59 | 2024 | Cimerli |
| Astellas Pharma US INC | $21.68 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hudson Stern listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.